文献速递焦虑、强迫与应激相关障碍

单剂量裸盖菇素与致幻蘑菇提取物在SAPAP3强迫症样过度自我修饰啮齿类模型中呈现显著的长期有益效应

Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming.
PubMed 文献 · Mol Psychiatry · 2024-10-11

在50只SAPAP3基因敲除小鼠中开展随机对照试验,单次腹腔注射裸盖菇素(4.4 mg/kg)、等剂量致幻蘑菇提取物或溶媒,盲法评估21天。溶媒组总自我修饰增加118.71±95.96%,裸盖菇素组降低14.60±17.90%,蘑菇提取物组降低19.20±20.05%(时间×处理交互p=0.0001);蘑菇提取物在减轻头体抽动和焦虑方面优于裸盖菇素。

要点

  • 单次裸盖菇素或致幻蘑菇提取物均可减少SAPAP3敲除小鼠的过度自我修饰,效应持续至7周。
  • 蘑菇提取物在减轻头体抽动和焦虑方面优于等剂量裸盖菇素。
  • 作者认为这些发现强烈支持在强迫症中开展裸盖菇素临床试验并进一步研究长期效应机制。

核心结论

  • 单次裸盖菇素或致幻蘑菇提取物在SAPAP3敲除小鼠中产生显著的长期有益效应,作者认为这些发现强烈支持在强迫症治疗中开展裸盖菇素临床试验并进一步研究长期效应机制。

研究设计与样本

  • 随机对照试验,50只SAPAP3基因敲除小鼠(28只雄性,22只雌性)随机接受单次腹腔注射裸盖菇素(4.4 mg/kg)、含相同裸盖菇素剂量的致幻蘑菇提取物或溶媒对照,由对分组盲法的评估者在第2、12、21天评估。
  • 溶媒组n=18,裸盖菇素组n=16,致幻蘑菇提取物组n=16;溶媒组5只、裸盖菇素组4只因出现皮肤病变被剔除,致幻蘑菇提取物组无剔除。

主要发现

  • 溶媒组(n=18)总自我修饰(主要结局指标)在21天观察期内增加118.71±95.96%,裸盖菇素组(n=16)降低14.60±17.90%,致幻蘑菇提取物组(n=16)降低19.20±20.05%(时间效应p=0.001,时间×处理交互p=0.0001)。
  • 头体抽动和焦虑等次要结局指标在21天内均显示显著改善。
  • 对裸盖菇素应答的小鼠(n=12)和对致幻蘑菇提取物应答的小鼠(n=13)中,单次治疗的有益效应持续长达7周。
  • 最初接受溶媒且无应答的小鼠,在单次给予裸盖菇素或致幻蘑菇提取物并再随访3周后,显示出明确且持久的治疗反应。
  • 致幻蘑菇提取物对自我修饰的总体效应与裸盖菇素相当,但在减轻头体抽动和焦虑方面显示更优效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obsessive compulsive disorder (OCD) is a highly prevalent disorder that causes serious disability. Available treatments leave 40% or more of people with OCD significantly symptomatic. There is an urgent need for novel therapeutic approaches. Mice that carry a homozygous deletion of the SAPAP3 gene (SAPAP3 KO) manifest a phenotype of excessive self-grooming, tic-like head-body twitches and anxiety. These behaviors closely resemble pathological self-grooming behaviors observed in humans in conditions that overlap with OCD. Following a preliminary report that the tryptaminergic psychedelic, psilocybin, may reduce symptoms in patients with OCD, we undertook a randomized controlled trial of psilocybin in 50 SAPAP3 KO mice (28 male, 22 female). Mice that fulfilled inclusion criteria were randomly assigned to a single intraperitoneal injection of psilocybin (4.4 mg/kg), psychedelic mushroom extract (encompassing the same psilocybin dose) or vehicle control and were evaluated after 2, 12, and 21 days by a rater blind to treatment allocation for grooming characteristics, head-body twitches, anxiety, and other behavioral features. Mice treated with vehicle (n = 18) manifested a 118.71 ± 95.96% increase in total self-grooming (the primary outcome measure) over the 21-day observation period. In contrast, total self-grooming decreased by 14.60 ± 17.90% in mice treated with psilocybin (n = 16) and by 19.20 ± 20.05% in mice treated with psychedelic mushroom extract (n = 16) (p = 0.001 for effect of time; p = 0.0001 for time × treatment interaction). Five mice were dropped from the vehicle group because they developed skin lesions; 4 from the psilocybin group and none from the psychedelic mushroom extract group. Secondary outcome measures such as head-body twitches and anxiety all showed a significant improvement over 21 days. Notably, in mice that responded to psilocybin (n = 12) and psychedelic mushroom extract (n = 13), the beneficial effect of a single treatment persisted up to 7 weeks. Mice initially treated with vehicle and non-responsive, showed a clear and lasting therapeutic response when treated with a single dose of psilocybin or psychedelic mushroom extract and followed for a further 3 weeks. While equivalent to psilocybin in overall effect on self-grooming, psychedelic mushroom extract showed superior effects in alleviating head-body twitches and anxiety. These findings strongly justify clinical trials of psilocybin in the treatment of OCD and further studies aimed at elucidating mechanisms that underlie the long-term effects to alleviate excessive self-grooming observed in this study. Prepared with BioRender ( https://www.biorender.com/ ).

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Brownstien M, Lazar M, Botvinnik A, et al. Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming. Mol Psychiatry. 2024. PMID: 39394457. doi:10.1038/s41380-024-02786-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。